Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Link opens in a new tab
Search content at UTMB Health Research Expert Profiles
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Managing allergic rhinitis: The role of pharmacotherapy
Adrienne M. Tiñana
, R. Matthew Bloebaum
, J. Andrew Grant
Internal Medicine
Research output
:
Contribution to journal
›
Article
›
peer-review
2
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Managing allergic rhinitis: The role of pharmacotherapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Pharmacotherapy
100%
Allergic Rhinitis
100%
Rhinorrhea
100%
Itch
100%
Intranasal Corticosteroids
100%
Moderate to Severe
50%
Severe Disease
50%
Response to Therapy
50%
Highly Effective
50%
Nasal
50%
Main Symptoms
50%
Pharmacological Therapy
50%
Cromolyn
50%
Ipratropium
50%
Adjusted Dose
50%
Sneezing
50%
Allergen Exposure
50%
Antihistamines
50%
First-generation Antihistamines
50%
H1-antihistamines
50%
Symptom Relief
50%
Conjunctival
50%
Adverse Effect Profile
50%
Lowest Effective Dose
50%
Avoidance Measures
50%
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacotherapy
100%
Allergic Rhinitis
100%
Antihistaminic Agent
100%
Rhinorrhea
66%
Corticosteroid
66%
Adverse Event
33%
Allergen
33%
Cromoglicic Acid
33%
Ocular Pruritus
33%
Nasal Pruritus
33%
Diseases
33%
Medicine and Dentistry
Drug Therapy
100%
Histamine Antagonist
100%
Allergic Rhinitis
100%
Rhinorrhea
66%
Corticosteroid
66%
Adverse Event
33%
Cromoglycate Disodium
33%
Allergen
33%
Nasal Pruritus
33%
Ocular Pruritus
33%
Diseases
33%